Tuberculosis (TB)—caused by infection with the mycobacterium Mycobacterium tuberculosis—is one of the top 10 leading causes of death worldwide with a total of 1.8 million people dying from the disease in 2015. TB is also the leading cause of death in HIV-infected individuals. TB usually attacks the lungs but can infect any part of the […]Read More
Author: I. Gardner & O. Hatley
Dr. Iain Gardner has been at Certara since 2011. He leads the science team that is responsible for further developments of the population-based physiologically-based PK/PD Simulators to meet the needs of our consortium members. — Oliver Hatley is a Research Scientist who has been working at Certara since 2013. He obtained his PhD investigating in vitro-in vivo extrapolation of intestinal metabolism from the Centre for Applied Pharmacokinetic Research (CAPKR) at the University of Manchester. Oliver is part of the translational sciences in DMPK group within Simcyp, and has lead development of the esterase organ and blood in vitro-in vivo scaling strategies. He is also involved in the development of special populations within the Simcyp Population-based Simulator.
Subscribe to Email Updates
- Predicting Drug Exposure During Pregnancy Using PBPK Models
- How AI Tech Is Changing Regulatory Writing
- New Tools Support Developing Better TB Drugs
- The Ides of March – FDA’s Pharmaceutical and Clinical Pharmacology Advisory Committee Meeting
- EMA Policy 0070 Compliance Tips from James Bond
- Modeling Delayed Outcomes in PK/PD Studies Using DDEs
- The Model-Informed Precision Dosing Revolution Is Coming
- Leveraging PBPK Modeling and Simulation for Neonatal and Infant Drug Development
- Accessing Grid Computing from Your Desktop for NLME
- Prediction of Liver Volume; One Size Doesn’t Fit All!